marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
BIOLASE Balance Sheet 2011-2024 | BIOL
Annual Balance Sheet BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
6.1 M | 9.55 M | -16.2 M | -1.38 M | 8 M | 2.79 M | -11.6 M | -8.76 M | -11.4 M | -31.6 M | 3.19 M | -906 K | -3.31 M |
Long Term Debt |
11.8 M | 13.1 M | 13.6 M | 16.2 M | - | 10.8 M | - | - | - | - | - | - | - |
Long Term Debt Current |
888 K | 638 K | 405 K | 305 K | 323 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 5.69 M | 11.5 M | 354 K | 1.86 M | 2.22 M | 1.2 M | 618 K | 804 K | 956 K |
Total Current Liabilities |
19.7 M | 17.8 M | 13.8 M | 11.2 M | 25.8 M | 16 M | 13.4 M | 18 M | 15.1 M | 16.2 M | 21.9 M | 19.4 M | 16.3 M |
Total Liabilities |
33.1 M | 33.3 M | 30.1 M | 31 M | 31.5 M | 27.4 M | 13.7 M | 19.9 M | 17.3 M | 17.3 M | 22.6 M | 20.2 M | 17.2 M |
Deferred Revenue |
2.45 M | 2.11 M | 2.26 M | 1.9 M | 2.24 M | 2.5 M | 2.65 M | 3.11 M | 3.24 M | 2.61 M | 3.75 M | 3.81 M | 2.3 M |
Retained Earnings |
-317 M | -296 M | -268 M | -251 M | -235 M | -217 M | -195 M | -178 M | -163 M | -143 M | -124 M | -112 M | -109 M |
Total Assets |
35.1 M | 38.2 M | 55.3 M | 41 M | 31.8 M | 38.5 M | 43 M | 41.9 M | 42.3 M | 59.4 M | 31 M | 32 M | 29.8 M |
Cash and Cash Equivalents |
6.57 M | 4.18 M | 30.2 M | 17.9 M | 5.79 M | 8.04 M | 11.6 M | 8.92 M | 11.7 M | 31.6 M | 1.44 M | 2.54 M | 3.31 M |
Book Value |
1.96 M | 4.89 M | 25.2 M | 10 M | 377 K | 11.1 M | 29.3 M | 22.1 M | 24.9 M | 42.1 M | 8.48 M | 11.8 M | 12.6 M |
Total Shareholders Equity |
-247 K | 4.89 M | 25.2 M | 10 M | 377 K | 11.1 M | 29.3 M | 22.1 M | 24.9 M | 42.1 M | 8.48 M | 11.8 M | 12.6 M |
All numbers in USD currency
Quarterly Balance Sheet BIOLASE
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 150 K | 11.2 M | 11.8 M | 11.3 M | 11.9 M | 12.5 M | 13.1 M | 12.8 M | 12.7 M | 13.7 M | 13.1 M | 12.1 M | 12.7 M | 16.3 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 13.5 M | 13.4 M | 13.3 M | 10.9 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
32.1 M | 32.8 M | 34.1 M | 33.1 M | 32.9 M | 32.3 M | 33.8 M | 33.3 M | 29 M | 29.2 M | 29.6 M | 30.1 M | 28.2 M | 28 M | 30 M | 31 M | 31 M | 31 M | 31 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M |
Deferred Revenue |
2.23 M | 2.13 M | 2.34 M | 2.45 M | 2.19 M | 2.24 M | 2.08 M | 2.11 M | 1.87 M | 2.49 M | 2.44 M | 2.26 M | 2.28 M | 2.06 M | 1.96 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 2.24 M | 2.24 M | 2.24 M | 2.24 M | 2.48 M | 2.48 M | 2.48 M | 2.48 M | 2.62 M | 2.56 M | 2.62 M | 2.62 M | 3.01 M | 3.01 M | 3.01 M | 3.01 M | 3.16 M | 3.16 M | 3.16 M | 3.16 M | 2.49 M | 2.49 M | 2.49 M | 2.49 M | 3.46 M | 3.46 M | 3.46 M | 3.46 M | 3.23 M | 3.23 M | 3.23 M | 3.23 M | 2.14 M | 2.14 M | 2.14 M | 2.14 M |
Retained Earnings |
-328 M | -326 M | -323 M | -317 M | -311 M | -307 M | -302 M | -296 M | -286 M | -278 M | -272 M | -268 M | -262 M | -259 M | -258 M | -251 M | -251 M | -251 M | -251 M | -235 M | -235 M | -235 M | -235 M | -217 M | -217 M | -217 M | -217 M | -195 M | -195 M | -195 M | -195 M | -178 M | -178 M | -178 M | -178 M | -163 M | -163 M | -163 M | -163 M | -143 M | -143 M | -143 M | -143 M | -124 M | -124 M | -124 M | -124 M | -112 M | -112 M | -112 M | -112 M | -109 M | -109 M | -109 M | -109 M |
Total Assets |
27.2 M | 30.6 M | 34.4 M | 35.1 M | 38.7 M | 39.6 M | 41.9 M | 38.2 M | 42.9 M | 50.9 M | 50.2 M | 55.3 M | 58.5 M | 61.2 M | 63.5 M | 41 M | 41 M | 41 M | 41 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 38.5 M | 38.5 M | 38.5 M | 38.5 M | 43 M | 43 M | 43 M | 43 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 42.3 M | 42.3 M | 42.3 M | 42.3 M | 59.4 M | 59.4 M | 59.4 M | 59.4 M | 31 M | 31 M | 31 M | 31 M | 32 M | 32 M | 32 M | 32 M | 29.8 M | 29.8 M | 29.8 M | 29.8 M |
Cash and Cash Equivalents |
3.44 M | 5.27 M | 6.39 M | 6.57 M | 7.81 M | 6.93 M | 6.53 M | 4.18 M | 9.96 M | 19.5 M | 21.8 M | 30.2 M | 33.6 M | 37.3 M | 40.8 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 5.79 M | 5.79 M | 5.79 M | 5.79 M | 8.04 M | 8.04 M | 8.04 M | 8.04 M | 11.6 M | 11.6 M | 11.6 M | 11.6 M | 8.92 M | 8.92 M | 8.92 M | 8.92 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 31.6 M | 31.6 M | 31.6 M | 31.6 M | 1.44 M | 1.44 M | 1.44 M | 1.44 M | 2.54 M | 2.54 M | 2.54 M | 2.54 M | 3.31 M | 3.31 M | 3.31 M | 3.31 M |
Book Value |
-4.88 M | -2.13 M | 269 K | 1.96 M | 5.88 M | 7.34 M | 8.16 M | 4.89 M | 13.9 M | 21.6 M | 20.6 M | 25.2 M | 30.3 M | 33.3 M | 33.5 M | 10 M | 10 M | 10 M | 10 M | 4.34 M | 4.34 M | 4.34 M | 4.34 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 29.3 M | 29.3 M | 29.3 M | 29.3 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 42.1 M | 42.1 M | 42.1 M | 42.1 M | 8.48 M | 8.48 M | 8.48 M | 8.48 M | 11.8 M | 11.8 M | 11.8 M | 11.8 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M |
Total Shareholders Equity |
-5.23 M | -4.33 M | -1.93 M | -247 K | 332 K | 6.62 M | 8.16 M | 4.89 M | 13.9 M | 21.6 M | 20.6 M | 25.2 M | 30.3 M | 33.3 M | 33.5 M | 10 M | 10 M | 10 M | 10 M | 377 K | 377 K | 377 K | 377 K | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 29.3 M | 29.3 M | 29.3 M | 29.3 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 42.1 M | 42.1 M | 42.1 M | 42.1 M | 8.48 M | 8.48 M | 8.48 M | 8.48 M | 11.8 M | 11.8 M | 11.8 M | 11.8 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M |
All numbers in USD currency